Contents
Issue 164 • July 2026
In association with
In Depth
The US manufacturing comeback
NAMs move into the mainstream
US continues pharma security agenda
AI tools bridging preclinical to FIH are now a necessity, not a nice to have
Data first: AI governance a fundamental pillar in the hospital pharmacy
ASCO26: AI innovations show promise in reducing the oncology RWD burden
The celebrity prescription: star power meets healthcare
AI in oncology: trials, tribulations and future opportunities